• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Pathophysiological Roles of Adrenomedullin (AM) and Proadrenomedullin N-terminal 20 Peptide (PAMP) in Cardiovascular and Renal Diseases

Research Project

Project/Area Number 08670808
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionMiyazaki Medical College

Principal Investigator

KATO Johji  Miyazaki Medical College, 1st DeptIntern Med, Research Associate, 医学部, 助手 (20274780)

Project Period (FY) 1996 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥2,500,000 (Direct Cost: ¥2,500,000)
Fiscal Year 1998: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1997: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1996: ¥1,100,000 (Direct Cost: ¥1,100,000)
KeywordsAdrenomedullin / PAMP / IRMA / Amidation / Hypotensive peptide / Hypertension / heart failure / renal failure / 腎臓疾患 / 心臓疾患
Research Abstract

(1) New assay methods for AM and PAMP :
To measure the plasma AM without extraction procedure, we have deve1oped immunoreactive radiometric assay (IRMA) for AM, and are elaborating the similar assay method for PAMP.Immunoreactive AM in the human plasma was found to consist of two molecular forms of peptides. These are a mature AM with amidated C-terndnus (mAM) and an intermediate form of glycine-extended AM (iAM) which may be converted to the mature form in the human blood. Two types of IRMAs have been established : one can detect wily the mAM and the other reacts both the mAM and iAM.
(2) Pathophysiological role of AM in cardiovascular and renal diseases :
Both the mAM and iAM levels in plasma were found to be elevated in patients with heart failure or renal failure at almost the constant ratio. The elevation of plasma AM was closely related to severity of the diseases, suggesting not only the role of AM acting against further deterioration of the diseases but also the possibility of AM as a useful parameter in examining and diagnosing the patients.
(3) Cardiovascular mortality or morbidity and plasma concentrations of AM or PAMP :
We have been measuring the plasma AM and PAMP concentrations of the local residences visiting us for a regular health check-up. Analysis of these measurements revealed that the plasma AM levels are increased in relation to aging in normotensive healthy subjects, while such a relation was not found in those with h ; pertension. We continue to follow them to see the relationship between cardiovascular mortality or morbidity and the plasma concentrations of AM or PAMP.

Report

(4 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • 1996 Annual Research Report
  • Research Products

    (32 results)

All Other

All Publications (32 results)

  • [Publications] KITAMURA, K.et al.: "Intermediate form of glycine-extended adrenomedullin is major circulating molecular form in human plasma." Biochem. Biophys. Res. Commun.244. 551-555 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] TSURUDA, T.et al.: "Adrenomedullin : A possible autocrine or paracrime inhibitor of hypertrophy of cardiomyocytes." Hypertension. 31. 505-510 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] MATSUI, E.et al.: "Lack of hypotensive effect of chronically infused proadrenomedullin N-terminal 20 peptide in rats." Horm. Metab. Res.30. 555-556 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] NAGATA, N.et al.: "Dissociation of adrenomedullin concentrations between plasma and cerebrospinal fluid in pregnant and non-pregnant women." Eur. J. Endocrinol.139. 611-614 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] KATO, J. et al.: "Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension." Hypertens. Res.in press.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] HIRAYAMA, N. et al.: "Molecular forms of circulating adrenomedullin in patients with congestive heart failure." J.Endocrinol.in press.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kitamura, K., Kato, J., Kawamoto, M., Tanaka, M., Chino, N., Kangawa, K.and Eto, T.: "Intermediate form of glycine-extended adrenomedullin is majour circulating molecular form in human plasma." Biochem.Biophys.Res.Commun.244. 551-555 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Tsuruda, T., Kato, J., Kitamura, K., Kuwasako, K., Imamura, T., Koiwaya, Y., Tsuji, T., Kangawa, K.and Eto, T.: "Adrenomedullin : a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes." Hypertension. 31. 505-510 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Matsui, E., Kato, J., Kitamura, K.and Eto, T.: "Lack of hypotensive effect of chronically infused proadrenomedullin N-terminal 20 peptide in rats." Horm, Metab.Res.30. 555-556 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Nagata, N., Kato, J., Kitamura, K., Kawamoto, M., Tanaka, N., Eto, T.and Takasaki, M.: "Dissociation of adrenomedullin concentrations between plasma and cerebrospinal fluid in pregnant and non-pregnant women." Eur.J.Endocrinol.139. 611-614 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kato, J., Kitamura, K., Matsui, E., Tanaka, M., Ishizaka, Y., Kangawa, K.and Eto, T.: "Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension." Hypertens.Res.(in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hirayama, N., Kitamura, K., Imamura, T., Kato, J., Koiwaya, Y.and Eto, T.: "Molecular forms of circulating adrenomedullin in patients with congestive heart failure." J.Endocrinol.(in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] KITAMURA,K.et al.: "Intermediate form of glycine-extended adrenomedullin is major circulating molecular form in human plasma." Biochem.Biophys.Res.Commun.244. 551-555 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] TSURUDA,T.et al.: "Adrenomedullin : A possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes." Hypertension. 31. 505-510 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] MATSUI,E.et al.: "Lack of hypotensive effect of chronically infused proadrenomedullin N-terminal 20 peptide in rats." Horm.Metab.Res.30. 555-556 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] NAGATA,N.et al.: "Dissociation of adrenomedullin concentrations between plasma and cerebrospinal fluid in pregnant and non-pregnant women." Eur.J.Endocrinol.139. 611-614 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] KATO,J.et al.: "Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension." Hypertens.Res.(in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] HIRAYAMA,N.et al.: "Molecular forms of circulating adrenomedullin in patients with congestive heart failure." J.Endocrinol.(in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] KHAN, A. I. at al.: "Hypotensive Effect of chronically infused adrenomedullin in conscious Wistar-Kyoto and spontaneously hypertensive rats." Clin. Exp. Pharmacol. Physiol.24. 139-142 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] ETOH, T. et al.: "Plasme proadrenomedullin N-terminal 20 peptide (PAMP) in patients with congestive heart failure." Horm. Metab. Res.29. 46-47 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] ISHIHARA, T. et al.: "Production of adrenomedullin in human vascular endothelial cells." Life Sci.60. 1763-1769 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] NAGATA, N. et al.: "The effect of hypothermic cardiopulmonary bypass on plasma adrenomedullin in adult cardiac surgical patients." Anesth. Analg.84. 1193-1197 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] KHAN, A. I. et al.: "Effect of chronically infused adrenomedullin in two-kidney, one-clip hypertensive rats" Eur. J. Pharmacol.333. 187-190 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] ETOH, T. et al.: "Cardiac Secretion of adrenomedullin by percutaneous transluminal coronary angioplasty." Horm. Metab. Res.29. 530-531 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] KATO, J, et al.: "Adrenomedullin" IOS Press ed. by MATRINEZ, A. AND CUTTITTA, F., 9 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kato J: "Plasma adrenomedullin concentration in patients with heart failure" J Clin Endocrinol Metab. 81. 180-183 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Eto T: "Plasma adrenomedullin and proadrenomedullin N-terminal 20 peptide in impaired renal function" Kidney Int. 49. S-148-S-149 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Etoh T: "Plasma proadrenomedullin N-terminal 20 peptide (PAMP) in patients with congestive heart failure" Horm Metab Res. (in press).

    • Related Report
      1996 Annual Research Report
  • [Publications] Ishihara T: "Production of adrenomedullin in human vascular endothelial cells" Life Sci. (in press).

    • Related Report
      1996 Annual Research Report
  • [Publications] Ishiyama Y: "Changes in cardiac adrenomedullin concentration in renovascular hypertensive rats" Hypertens Res. (in press).

    • Related Report
      1996 Annual Research Report
  • [Publications] Khan AI: "Hypotensive effect of chronically infused adrenomedullin in consciousd Wistar-Kyoto and spontaneously hypertensive rats" Clin Exp Pharmacol Physiol. (in press).

    • Related Report
      1996 Annual Research Report
  • [Publications] 加藤丈司: "動脈硬化+高脂血症研究ストラテジー" 山田信博、佐藤靖史編、秀潤社, 3 (1996)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi